NM_001852.4:c.630+13G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001852.4(COL9A2):​c.630+13G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,613,654 control chromosomes in the GnomAD database, including 24,982 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1917 hom., cov: 32)
Exomes 𝑓: 0.17 ( 23065 hom. )

Consequence

COL9A2
NM_001852.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0370

Publications

12 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 1-40311080-C-A is Benign according to our data. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40311080-C-A is described in CliVar as Benign. Clinvar id is 258392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.630+13G>T intron_variant Intron 12 of 31 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.630+13G>T intron_variant Intron 12 of 31 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.933+13G>T intron_variant Intron 11 of 30 1
COL9A2ENST00000417105.6 linkc.348+13G>T intron_variant Intron 12 of 13 5 ENSP00000388493.2 H0Y409
COL9A2ENST00000488463.6 linkn.681+13G>T intron_variant Intron 11 of 13 5

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21272
AN:
152082
Hom.:
1915
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0532
Gnomad AMI
AF:
0.191
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.412
Gnomad SAS
AF:
0.0977
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.122
GnomAD2 exomes
AF:
0.174
AC:
43816
AN:
251264
AF XY:
0.168
show subpopulations
Gnomad AFR exome
AF:
0.0548
Gnomad AMR exome
AF:
0.248
Gnomad ASJ exome
AF:
0.132
Gnomad EAS exome
AF:
0.385
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.159
Gnomad OTH exome
AF:
0.160
GnomAD4 exome
AF:
0.168
AC:
245050
AN:
1461454
Hom.:
23065
Cov.:
37
AF XY:
0.166
AC XY:
120408
AN XY:
727042
show subpopulations
African (AFR)
AF:
0.0497
AC:
1662
AN:
33468
American (AMR)
AF:
0.243
AC:
10857
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.137
AC:
3583
AN:
26132
East Asian (EAS)
AF:
0.431
AC:
17091
AN:
39698
South Asian (SAS)
AF:
0.0987
AC:
8508
AN:
86244
European-Finnish (FIN)
AF:
0.187
AC:
9969
AN:
53418
Middle Eastern (MID)
AF:
0.0818
AC:
456
AN:
5576
European-Non Finnish (NFE)
AF:
0.165
AC:
183126
AN:
1111832
Other (OTH)
AF:
0.162
AC:
9798
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
12393
24786
37180
49573
61966
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6664
13328
19992
26656
33320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.140
AC:
21274
AN:
152200
Hom.:
1917
Cov.:
32
AF XY:
0.141
AC XY:
10462
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0532
AC:
2209
AN:
41552
American (AMR)
AF:
0.201
AC:
3074
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.135
AC:
470
AN:
3470
East Asian (EAS)
AF:
0.412
AC:
2125
AN:
5152
South Asian (SAS)
AF:
0.0971
AC:
468
AN:
4818
European-Finnish (FIN)
AF:
0.178
AC:
1882
AN:
10602
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.156
AC:
10591
AN:
67986
Other (OTH)
AF:
0.121
AC:
255
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
896
1792
2687
3583
4479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.136
Hom.:
955
Bravo
AF:
0.141
Asia WGS
AF:
0.228
AC:
793
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 30, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epiphyseal dysplasia, multiple, 2 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
7.7
DANN
Benign
0.86
PhyloP100
-0.037
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3737815; hg19: chr1-40776752; COSMIC: COSV65607609; COSMIC: COSV65607609; API